4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000899243-22-019216
Chief Executive Officer sold 29,135 shares at $4.33 ($126,257)
From the SEC's structured data for this filing
Trades in this filing
Brainard Diana · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-05-18 | Sale : show line 1 in the form | −29,135 | $4.33 | $126,257 | 492,165 | D |
| Open-market sales · 29,135 sh · avg $4.33 · $126,257 | ||||||
Loading xslF345X03/doc4.xml…